Clay Siegall & His Important Role In The Fight Against Cancer

Cancer is one of life’s deadly illnesses especially when being compared to other illnesses in society. This disease has touched of us directly or indirectly in some form or another. Cancer Research has been going on for many years while mostly having little success in wiping the disease out for good. Luckily in the 21st Century cancer research has stepped up it’s game and is supplying the world with much better treatments. One of these special treatments come in the form of Antibody Based Therapies. These therapies stand out when being compared to treatments of the past such as Chemotherapy. Antibody Drug Conjugates are the weapon of choice as they’ll directly deliver cell killing agents straight into cancerous cells. This design and action of the medications actually spare other good cells within the body which decreases any nasty side effects.

Have you ever heard of Seattle Genetics? How about Clay Siegall? Well if you haven’t, Dr. Clay Siegall is the president and (CEO) of Seattle Genetics, which is a Biotech Company that deliver and commercialize breakthrough therapies. Seattle Genetics is the premier organization in this specific industry and it’s flagship drug (ADCETRIS) is the weapon of choice. Dr. Clay Siegall has been in this business for decades and has worked with many of the top cancer research organizations such as Bristol Myers Squibb, The National Institute of Health, as well as The National Cancer Institute. His strong passion and persistence can’t be denied and in 2015, Forbes ranked Seattle Genetics as one of the nation’s fastest growing companies. With such success come significant growth and this company is no exception. As of today this Bothell, Washington based company has well over 800 employees and staff members.

Siegall has his foot on the gas when it comes to eradicating cancer itself. Siegall implements the principles of drug development, scientific innovation, and rigorous research which has made this company into such a huge success. The future is looking bright in the fight against cancer and Dr. Clay Siegall is steering the ship to success.

Clay Siegall’s Revolutionary Stance For Fighting Cancer

Living in today’s modern society illness seems to be running rampant. Cancer in particular, has seemed to touch most of our lives in one way or another and it is one of the most common diseases in the world as of today. The good thing about this is that there are some very good cancer fighting drugs on the market and in production. There is one company in particular that is leading the way among it’s contemporaries and setting new beneficial trends in this huge pharmaceutical market.Seattle Genetics, located in the great State of Washington, is transcending the game with it’s revolutionary cancer fighting drugs and it’s (CEO) Clay Siegall is leading the charge.

Dr. Clay Siegall co-founded the company back in 1998 and is now it’s current President and CEO. Dr. Siegall has a strong passion in what he does and his commitment to helping others is surely evident. This George Washington University Graduate has a Ph.D in Genetics and a prestige B.S. in Zoology from the University of Maryland. Seattle Genetics has become known as the leader in (ADC) Antibody Drug Conjugates thanks to the effectiveness of these cell-killing agents. The company has one of the most popular and successful drugs known as(Brentuximabvedotin)and it is commercially available in over 60 countries worldwide. Dr. Siegall’s vision can’t be denied since he is the heart and soul of the entire organization. This scientific doctor has with many companies throughout the years such as the National Cancer Institute,Bristol-Myers Squibb, and the National Institute of Health before Seattle Genetics’ inception.

The good doctor’s huge resume of accomplishments can’t be understated as he is the author of well over 70 publications, Entrepreneur of the year, and he currently holds up to 15 patents. The fight against cancer is underway and is certainly getting stronger thanks to Dr. Clay Siegall and his prominent company Seattle Genetics.